Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial
Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial
复制标题
omega-3 脂肪酸对精神分裂症患者代谢综合征的影响:一项为期 12 周的随机安慰剂对照试验
DOI:
10.1007/s00213-018-5136-9
复制
发表时间:
2018-12
影响因子:
3.4
通讯作者:
Zhang Chen
中科院分区:
文献类型:
--
作者:
Xu Feikang;Fan Weixing;Wang Weiping;Tang Wei;Yang Fuyin;Zhang Yi;Cai Jun;Song Lisheng;Zhang Chen
RationaleIndividuals with schizophrenia are at increased risk of developing metabolic syndrome (MetS) due to their lifestyle and antipsychotic treatment. Our previous study showed that patients with both schizophrenia and MetS present an increased expression and production of tumor necrosis factor-alpha (TNF-alpha). Omega-3 fatty acids have a documented role in suppressing TNF-alpha; therefore, we hypothesized that they may be of value in relieving inflammation and improving metabolic disturbance in patients with both schizophrenia and MetS.ObjectivesThis study employed a randomized placebo-controlled trial to investigate the effects of omega-3 fatty acids on MetS in patients with schizophrenia.MethodsWe recruited 80 patients with both schizophrenia and MetS who received long-term olanzapine monotherapy. The patients were randomly assigned to the OMG-3 group (n= 40) or the placebo group (n= 40).ResultsPatients with both schizophrenia and MetS had significantly higher levels of TNF-alpha than the control subjects (Z= − 4.37,P< 0.01). There was a significant correlation between omega-3 fatty acid treatment and reduced triglyceride (TG) levels (Fgroup × time= 13.42; df = 1, 66;P< 0.01) when the patients completed this study. Along with metabolic improvement, omega-3 fatty acids decreased TNF-alpha levels after 12 weeks of treatment (Fgroup × time= 6.71; df = 1, 66;P= 0.012). We also found that the extent of TNF-alpha decrease was significantly correlated with that of TG decrease (r= 0.38,P= 0.001).ConclusionsOur findings provide suggestive evidence that omega-3 fatty acids have beneficial effects on TG metabolism in patients with both schizophrenia and MetS that parallel decreased inflammation levels.
登录
查看更多内容
影响因子:
5.3
作者:
Zhang Chen;Chen Mei-Juan;Wu Guo-Jun;Wang Zuo-Wei;Rao Shun-Zeng;Zhang Yi;Yi Zheng-Hui;Yang Wei-Min;Gao Ke-Ming;Song Li-Sheng
通讯作者:
Song Li-Sheng
影响因子:
9.3
作者:
O'Mahoney LL;Matu J;Price OJ;Birch KM;Ajjan RA;Farrar D;Tapp R;West DJ;Deighton K;Campbell MD
通讯作者:
Campbell MD
影响因子:
2.9
作者:
von Schacky C
通讯作者:
von Schacky C
影响因子:
5.5
作者:
E. Rahmani;M. Jamilian;Bahareh Dadpour;Zahra Nezami;Z. Vahedpoor;Samaneh Mahmoodi;E. Aghadavod;M. Taghizadeh;Abolfazl Beiki Hassan;Z. Asemi
通讯作者:
E. Rahmani;M. Jamilian;Bahareh Dadpour;Zahra Nezami;Z. Vahedpoor;Samaneh Mahmoodi;E. Aghadavod;M. Taghizadeh;Abolfazl Beiki Hassan;Z. Asemi
影响因子:
3.7
作者:
Beumer, Wouter;Drexhage, Roosmarijn C.;Cohen, Dan
通讯作者:
Cohen, Dan